| Date | Ticker | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 1, 2026 | CVNA👔 CARVANA CO. | JENKINS MARK W. Chief Financial Officer | sell | 520 | $391.35 | $204K |
| May 1, 2026 | CVNA👔 CARVANA CO. | JENKINS MARK W. Chief Financial Officer | sell | 2,790 | $395.33 | $1.10M$1M+ |
| May 1, 2026 | CVNA👔 CARVANA CO. | Palmer Stephen R Vice President of Accounting | sell | 1,000 | $395.32 | $395K |
| May 1, 2026 | Merck & Co Inc | Li Dean Y | sell | 2,326 | $110.03 | $256K |
| May 1, 2026 | Merck & Co Inc | Guindo Chirfi | exercise | 1,967 | - | N/A |
| May 1, 2026 | CVNA👔 CARVANA CO. | HUSTON BENJAMIN E. Chief Operating Officer | sell | 748 | $381.68 | $285K |
| May 1, 2026 | CVNA👔 CARVANA CO. | HUSTON BENJAMIN E. Chief Operating Officer | sell | 560 | $387.09 | $217K |
| May 1, 2026 | CVNA👔 CARVANA CO. | HUSTON BENJAMIN E. Chief Operating Officer | sell | 520 | $383.73 | $200K |
| May 1, 2026 | CVNA👔 CARVANA CO. | HUSTON BENJAMIN E. Chief Operating Officer | sell | 410 | $389.18 | $160K |
| May 1, 2026 | ULS👔 UL Solutions Inc. | Scanlon Jennifer F. President and CEO | sell | 9,532 | $91.43 | $872K |
| May 1, 2026 | CVNA👔 CARVANA CO. | HUSTON BENJAMIN E. Chief Operating Officer | sell | 480 | $388.36 | $186K |
| May 1, 2026 | CVNA👔 CARVANA CO. | HUSTON BENJAMIN E. Chief Operating Officer | sell | 260 | $392.36 | $102K |
| May 1, 2026 | Pharvaris N.V. | Lu Peng Chief Medical Officer | sell | 3,733 | $30.06 | $112K |
| May 1, 2026 | Pharvaris N.V. | Lu Peng Chief Medical Officer | sell | 15,000 | $30.24 | $454K |
| May 1, 2026 | ODD👔 Oddity Tech Ltd | Drucker Mann Lindsay Global Chief Financial Officer | sell | 9,600 | $15.62 | $150K |
| May 1, 2026 | Pharvaris N.V. | Schikan Johannes Gerardus Christiaan Petrus | sell | 3,830 | $30.07 | $115K |
| May 1, 2026 | Pharvaris N.V. | Schikan Johannes Gerardus Christiaan Petrus | sell | 28,400 | $30.30 | $861K |
| May 1, 2026 | Merck & Co Inc | Oosthuizen Johannes Jacobus | exercise | 1,377 | - | N/A |
| May 1, 2026 | Merck & Co Inc | Li Dean Y | exercise | 4,722 | $110.03 | $520K |
| May 1, 2026 | Pharvaris N.V. | Lesage Anne Chief Early Development | sell | 3,700 | $30.08 | $111K |